Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 12 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male SubjectsCompletedNCT03748628Phase 1
- Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver DiseaseTerminatedNCT03748511
- Repeatability and Reproducibility of Multiparametric MRICompletedNCT03743272
- Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver DiseaseCompletedNCT03738358Not applicable
- The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled StudyStatus unknownNCT03734510Not applicable
- A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk PopulationsCompletedNCT03726827
- Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLDStatus unknownNCT03725631Not applicable
- Dapagliflozin Efficacy and Action in NASHCompletedNCT03723252Phase 3
- Liver Health and Metabolic Function in People With ObesityCompletedNCT03701828Not applicable
- French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort)CompletedNCT03695796Not applicable
- De Novo Lipogenesis in Severity of NAFLDCompletedNCT03683589
- Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control SubjectsCompletedNCT03681457Phase 1
- Effects of Exercise on VLDL-TG MetabolismCompletedNCT03678727
- Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)TerminatedNCT03676231Phase 2
- Technical Validation of MR Biomarkers of Obesity-Associated NAFLDCompletedNCT03674528
- An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney FunctionCompletedNCT03674476Phase 1
- Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic SteatohepatitisCompletedNCT03664596Not applicable
- ObeSity Related Colorectal Adenoma RiskCompletedNCT03663062
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)Status unknownNCT03648554Phase 4
- Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver DiseaseStatus unknownNCT03648086Not applicable
- Antidiabetic Drugs for Steatotic Liver DiseaseCompletedNCT03646292Phase 4
- Plant Sterols and Plant Stanols and Liver InflammationStatus unknownNCT03627819Not applicable
- Hydrogen-rich Water for Non-alchoholic Fatty Liver DiseaseCompletedNCT03625362Not applicable
- Oral Dietary Fucoxanthin Rich Supplement for Liver HealthStatus unknownNCT03625284Not applicable
- Effect of Probiotic and Smectite Gel on NAFLDCompletedNCT03614039Not applicable
- Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)Status unknownNCT03613480Not applicable
- Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy VolunteersCompletedNCT03610945Phase 1
- Early Detection of Advanced Fatty Liver DiseaseCompletedNCT03608748
- Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty LiverStatus unknownNCT03604016Phase 4
- Liver Fibrosis in Peri-menopausal WomenStatus unknownNCT03602573
- Hepatic Glycogen and Fat OxidationCompletedNCT03593343Not applicable
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseCompletedNCT03590626Not applicable
- Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic SteatohepatitisTerminatedNCT03587831Not applicable
- Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD)Status unknownNCT03587298
- Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD.CompletedNCT03583437Not applicable
- Association Between Nonalcoholic Fatty Liver Disease and Acute PancreatitisCompletedNCT03566173
- Intragastric Balloon With Lifestyle Intervention vs. Lifestyle Intervention in Obese Patients With NASHWithdrawnNCT03538236Not applicable
- Effect of DMR in the Treatment of NASHCompletedNCT03536650Not applicable
- Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model StudyStatus unknownNCT03534908
- Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLDCompletedNCT03528707Not applicable
- Hepatic Metabolic Changes in Response to Glucagon InfusionCompletedNCT03526445Not applicable
- Bariatric Surgery Versus Non-alcoholic Steato-hepatitisCompletedNCT03524365Not applicable
- YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT03512184Not applicable
- Effects of Probiotic on Inflammation and Microbiota in Patients With NASHTerminatedNCT03511365Phase 1/2
- Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases SeverityStatus unknownNCT03492879Not applicable
- Proof of Concept ELectro-Stimulation of Muscles to resolVe Insulin Resistance in NASHCompletedNCT03490370Not applicable
- Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver DiseaseStatus unknownNCT03487068Not applicable
- Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or PlaceboTerminatedNCT03479125
- Probiotics in NASH Patients - PROBILIVER TRIALStatus unknownNCT03467282Not applicable
- Effects of Tomato Products in Children With NAFLDStatus unknownNCT03463967Not applicable
- Effectiveness of Exercise Applications on Hepatic Steatosis and Physical Fitness in Patients With NAFLDCompletedNCT03461562Not applicable
- A Study of Experimental Medication BMS-986036 Given to Healthy ParticipantsCompletedNCT03445208Phase 1
- Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women.CompletedNCT03444233Phase 4
- Effects of Carnitine Supplementation on Liver and MuscleCompletedNCT03439917Not applicable
- Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver DiseaseWithdrawnNCT03437720Phase 2
- Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver DiseaseCompletedNCT03434613Phase 4
- Coffee Consumption and NASH in the French Population.CompletedNCT03432377
- Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO).Status unknownNCT03426111Not applicable
- Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 PharmacokineticsCompletedNCT03392779Phase 1
- Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver FibrosisStatus unknownNCT03386890
- The Effects of Hesperidin and Flaxseed on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver DiseaseStatus unknownNCT03377153Not applicable
- The Effects of Hesperidin on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver DiseaseStatus unknownNCT03377140Not applicable
- Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLDStatus unknownNCT03375580Not applicable
- Predictable MR Index for Nonalcoholic Steatohepatitis (NASH)CompletedNCT03375008Not applicable
- Obstructive Sleep Apnea and Non-alcoholic Fatty Liver DiseaseStatus unknownNCT03373643Not applicable
- High-fat Overfeeding, Hepatokines and Appetite RegulationCompletedNCT03369145Not applicable
- Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese PopulationCompletedNCT03366987
- RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver DiseaseTerminatedNCT03365531Not applicable
- A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the LiverCompletedNCT03357380Phase 1
- Lifestyle Intervention in Fatty Liver (NAFLD)Status unknownNCT03354247Not applicable
- A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT03350165Phase 2
- Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASHTerminatedNCT03332940Phase 1
- The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty LiverCompletedNCT03319199Not applicable
- Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle MedicineCompletedNCT03300661Not applicable
- Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DMWithdrawnNCT03291249Phase 2
- Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScanCompletedNCT03289897Not applicable
- Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT03281083Phase 2
- Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C VirusCompletedNCT03276039
- Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT03261739Phase 1
- Efficacy and Safety of Fermented Ginseng Powder on Liver FunctionCompletedNCT03260543Not applicable
- Hepatic Urea Nitrogen Handling in Patients With NASHActive, not recruitingNCT03260036
- Copeptin and Nonalcoholic Fatty Liver DiseaseStatus unknownNCT03254563
- Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD PatientsCompletedNCT03250572
- Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver DiseaseCompletedNCT03245606
- The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver DiseaseCompletedNCT03222206Phase 4
- Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy VolunteersCompletedNCT03213145Phase 1
- Determinants of Liver Fat CompositionCompletedNCT03211299
- Response of NAFLD Patients to Mediterranean DietCompletedNCT03203486Not applicable
- Efficacy and Safety of Berberine in Non-alcoholic SteatohepatitisTerminatedNCT03198572Phase 2
- Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRICompletedNCT03198104
- Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease)CompletedNCT03186859Not applicable
- Histological Improvement of NASH With PrebioticCompletedNCT03184376Not applicable
- Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)Status unknownNCT03183193Not applicable
- Guangzhou Nutrition and Health Study (GNHS)Active, not recruitingNCT03179657
- Effect of Non-alcoholic Fatty Liver Disease on Kidney FunctionsStatus unknownNCT03172650
- A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)WithdrawnNCT03163810Not applicable
- Global Osteopathic Treatment for Patients With NAFLDStatus unknownNCT03156881Not applicable
- The Liver Health Study for Patients with NAFLDCompletedNCT03151798Not applicable
- The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in AdultsTerminatedNCT03142867
- Mastiha Treatment for Obese With NAFLD DiagnosisCompletedNCT03135873Not applicable